New Biosimilars Markets Research Reports by RNCOS E-Services Recently Published at

25 May 2012 • by Natalie Aster

LONDON - Market Publishers Ltd informs that new in-demand RNCOS E-Services reports on various biosimilars markets have been added to its catalogue.

EPO Biosimilars Market Forecast to 2015. Erythropoietin (EPO) is among the most widely manufactured recombinant biosimilar proteins in the world. Forecasts say the promising EPO biosimilars market will reach the size of USD 275 million by 2015-end. Patent expirations of key epoietin drugs, Epogen and Procrit, are expected to spur the market growth in near future. The report aims at providing reliable and complete information on the EPO biosimilar market, covering the trends and drivers fuelling growth in the sector, competitive landscape, future outlook …

G-CSF Biosimilars Market Forecast to 2015. In 2010, the granulocyte colony-stimulating factor (G-CSF) biosimilars had a 33% share in the global biosimilars market. It is expected that the patent expiries of Neupogen (filgrastim) in 2013 and Neulasta (pegfilgrastim) in 2015 will make the way for the entry of G-CSF biosimilars into the market. By 2015, the G-CSF biosimilars market is anticipated to touch the USD 350 million-mark. The study provides extensive research of the market for the global G-CSF biosimilars and looks into the recent activities in the segment …

HGH Biosimilars Market Forecast to 2015. Human growth hormones (HGH) biosimilars are highly important as they help overcome the growth hormones’ inadequacy in both adults and children. They also have multiple applications in several other diseases, like the treatment for chronic kidney failure, cachexia, liver disease and short bowel syndrome. In 2010, HGH biosimilars captured around one-fourth of the global biosimilars market. The report provides a thorough study of the HGH biosimilars, besides talking about ‘what is going on’ in the market …

More new market research reports by the publisher can be found at RNCOS E-Services page.


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970